Foreign-invested firms calling for withdrawal of reference pricing system

Foreign-invested pharmaceutical firms have called for the government to cautiously introduce the reference pricing system (RPS), which has been promoted by the government in a bid to ensure better finance stability in the national health insurance sector, citing that the RPS may aggravate the public's financial burden and impair better medical service.

Notably, the multinational drug makers ...